Stock listing

NASDAQ:VYGR Voyager Therapeutics, Inc. Stock

Home listing (NASDAQ) of Voyager Therapeutics, Inc.

Follow Voyager Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:VYGR

$1.90 USD -0.16 (-7.8%)

Close on Oct 16, 2026

Voyager Therapeutics, Inc. logo
Ticker
NASDAQ:VYGR
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Voyager Therapeutics (NASDAQ:VYGR) Q3 2025 Earnings Call

    Tue, Nov 11, 2025 · 3:20 PM ET

    Watch Transcript

  • Voyager Therapeutics (NASDAQ:VYGR) Q2 2025 Earnings Call

    Tue, Aug 12, 2025 · 4:30 PM ET

    Watch Transcript

  • Voyager Therapeutics (NASDAQ:VYGR) Q1 2025 Earnings Call

    Tue, May 13, 2025 · 4:30 PM ET

    Watch Transcript

Latest news

Voyager Technologies, Inc. Completes $402.5 Million Convertible Senior Notes Offering

Sep 28, 2026

Voyager Technologies, Inc. Announces Proposed Convertible Senior Notes Offering

Sep 22, 2026

Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026

Jul 13, 2026

Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026

Jun 29, 2026

Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference

Jun 11, 2026

Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease

Jun 1, 2026

Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026

May 13, 2026

Voyager Reports First Quarter 2026 Financial and Operating Results

May 7, 2026

Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

Apr 27, 2026

Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 9, 2026

All Voyager Therapeutics, Inc. news

Decks

Voyager Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 104 in all · newest Sep 28, 2026 · oldest 2019
Calls
16 calls with a replay · 16 with a transcript · latest Nov 11, 2025
Decks
9 decks · latest May 15, 2026

Where Voyager Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:VYGR · Home listing · This pageNASDAQUnited StatesUSD
Tradegate:VT6TradegateGermanyEUR
BMV:VYGRBMVMexicoMXN
gettex:VT6gettexGermanyEUR
LS Exchange:A143XJLS ExchangeGermanyEUR
Lang & Schwarz:A143XJLang & SchwarzGermanyEUR
Frankfurt:VT6FrankfurtGermanyEUR
BIVA:VYGRBIVAMexicoMXN
BOATS:VYGRBOATSUnited StatesUSD
Dusseldorf:VT6DusseldorfGermanyEUR
Hamburg:VT6HamburgGermanyEUR
Munich:VT6MunichGermanyEUR
Stuttgart:VT6StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Voyager Therapeutics, Inc.